Piramal Pharma Limited (BOM:543635)
200.90
+0.20 (0.10%)
At close: Jul 11, 2025
Piramal Pharma Revenue
In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 91.51B INR with 11.99% growth. Piramal Pharma had revenue of 27.54B in the quarter ending March 31, 2025, with 7.90% growth.
Revenue
91.51B
Revenue Growth
+11.99%
P/S Ratio
3.02
Revenue / Employee
13.62M
Employees
6,719
Market Cap
276.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 91.51B | 9.80B | 11.99% |
Mar 31, 2024 | 81.71B | 10.90B | 15.39% |
Mar 31, 2023 | 70.82B | 3.47B | 5.16% |
Mar 31, 2022 | 67.34B | 8.47B | 14.39% |
Mar 31, 2021 | 58.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,561.48B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Hindustan Unilever | 631.21B |